Primary hypertrophic osteoarthropathy: clinical, radiologic, and scintigraphic characteristics.

PubWeight™: 1.11‹?› | Rank: Top 10%

🔗 View Article (PMID 11343811)

Published in Arch Med Res on May 09, 2001

Authors

Z Jajic1, I Jajic, T Nemcic

Author Affiliations

1: Department of Rheumatology, Physical Medicine and Rehabilitation, School of Medicine, University of Zagreb, University Hospital Sestre Milosrdnice, Zagreb, Croatia.

Articles by these authors

Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res (2002) 3.16

Low BMD is less predictive than reported falls for future limb fractures in women across Europe: results from the European Prospective Osteoporosis Study. Bone (2005) 1.80

Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis. Results of a randomized, placebo-controlled, phase II study. Arthritis Rheum (1995) 1.67

Incidence of limb fracture across Europe: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (2002) 1.56

Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (2003) 1.45

Hypertrophic osteoarthropathy: consensus on its definition, classification, assessment and diagnostic criteria. J Rheumatol (1993) 1.30

The clinical spectrum of pachydermoperiostosis (primary hypertrophic osteoarthropathy). Medicine (Baltimore) (1991) 1.23

Hip geometry, bone mineral distribution, and bone strength in European men and women: the EPOS study. Bone (2000) 1.23

Prevalent vertebral deformity predicts incident hip though not distal forearm fracture: results from the European Prospective Osteoporosis Study. Osteoporos Int (2001) 1.20

The spectrum of dermatological symptoms of pachydermoperiostosis (primary hypertrophic osteoarthropathy): a genetic, cytogenetic and ultrastructural study. Clin Exp Rheumatol (1992) 1.08

Cutaneous fibrinolytic activity in primary hypertrophic osteoarthropathy. Scand J Rheumatol (1987) 0.97

Whom to treat? The contribution of vertebral X-rays to risk-based algorithms for fracture prediction. Results from the European Prospective Osteoporosis Study. Osteoporos Int (2006) 0.93

Falls explain between-center differences in the incidence of limb fracture across Europe. Bone (2002) 0.88

Determinants of the size of incident vertebral deformities in European men and women in the sixth to ninth decades of age: the European Prospective Osteoporosis Study (EPOS). J Bone Miner Res (2003) 0.80

Minor but important symptoms and signs in primary hypertrophic osteoarthropathy. Clin Exp Rheumatol (2001) 0.78

Pachydermoperiostosis (primary hypertrophic osteoarthropathy): in vitro evidence for abnormal fibroblast proliferation. Clin Exp Rheumatol (1992) 0.77

[Pirprofen, indomethacin and placebo in ankylosing spondylitis. Double-blind comparison]. Nouv Presse Med (1982) 0.76

The European spine phantom: reply to Dr Peter Tothill's letter. Osteoporos Int (1996) 0.75

Femoral head osteonecrosis in primary hypertrophic osteoarthropathy. Ann Rheum Dis (1993) 0.75

Blue coloured skin in psoriatic arthritis. Clin Exp Rheumatol (2001) 0.75

Proposal for a better clinical recognition of Sacroiliits. J Clin Rheumatol (1999) 0.75

The medical and surgical treatment of finger clubbing and hypertrophic osteoarthropathy. A blind study with colchicine and a surgical approach to finger clubbing reduction. Clin Exp Rheumatol (1992) 0.75

Reactivation of primary hypertrophic osteoarthropathy by bronchogenic carcinoma. Clin Exp Rheumatol (2001) 0.75

[Some aspects of organization of the health care in Sweden]. Lijec Vjesn (1975) 0.75

Hypertrophic osteoarthropathy after cerebrovascular insult. Clin Exp Rheumatol (2000) 0.75